Vaktrommet AS – Trademark Portfolio

Entity Type: 03

Vaktrommet AS holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MIGENIC. The owner is based in Oslo.

Myrhaugen 17 C

Oslo N0752 , NO

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MIGENIC
MIGENIC
Registered 2018

Trademark Classifications

Vaktrommet AS's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does Vaktrommet AS have?

Vaktrommet AS has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Vaktrommet AS file in?

Vaktrommet AS files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 35 covers advertising; business management; business administration; office functions.

What are Vaktrommet AS's most well-known trademarks?

Vaktrommet AS's registered trademark portfolio includes well-known marks such as MIGENIC. These are among 1 currently registered trademark in the portfolio.

What is Vaktrommet AS's trademark registration success rate?

Vaktrommet AS has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.